Ganciclovir/Valganciclovir Prophylaxis Decreases Cytomegalovirus-Related Events and Bronchiolitis Obliterans Syndrome after Lung Transplantation
Open Access
- 15 March 2008
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 46 (6) , 831-839
Abstract
Background. Until recently, cytomegalovirus (CMV) infection represented a major threat to lung transplant recipients. Preliminary studies have shownKeywords
This publication has 22 references indexed in Scilit:
- Combined CMV Prophylaxis Improves Outcome and Reduces the Risk for Bronchiolitis Obliterans Syndrome (BOS) after Lung TransplantationTransplantation, 2006
- A Trial of Valganciclovir Prophylaxis for Cytomegalovirus Prevention in Lung Transplant RecipientsAmerican Journal of Transplantation, 2005
- Extended Ganciclovir Prophylaxis in Lung TransplantationThe Journal of Heart and Lung Transplantation, 2005
- Delay of CMV infection in high‐risk CMV mismatch lung transplant recipients due to prophylaxis with oral ganciclovirClinical Transplantation, 2004
- Clinical significance of cytomegalovirus (CMV) antigenemia in the prediction and diagnosis of CMV gastrointestinal disease after allogeneic hematopoietic stem cell transplantationBone Marrow Transplantation, 2003
- Cytomegalovirus UL97 Phosphotransferase Mutations That Affect Susceptibility to GanciclovirThe Journal of Infectious Diseases, 2002
- Comparison of the efficacy and cost effectiveness of pre-emptive therapy as directed by CMV antigenemia and prophylaxis with ganciclovir in lung transplant recipients11We are indebted to the dedicated staff of the University of Washington Lung Transplant program caring for the lung transplant recipients.The Journal of Heart and Lung Transplantation, 2000
- Prospective study of the value of transbronchial lung biopsy after lung transplantationEuropean Respiratory Journal, 1996
- EFFICACY OF A 6-WEEK PROPHYLACTIC GANCICLOVIR REGIMEN AND THE ROLE OF SERIAL CYTOMEGALOVIRUS ANTIBODY TESTING IN LUNG TRANSPLANT RECIPIENTSTransplantation, 1995
- Cytomegalovirus Infection in Heart-Lung Transplant Recipients: Risk Factors, Clinical Associations, and Response to TreatmentThe Journal of Infectious Diseases, 1991